JADPRO Live 2017 Activities
Updates in Heme Malignancy Side Effects
Myeloproliferative Neoplasms Updates
Knowledge Center: Oral Oncolytics
Narratives: HER2-Positive Breast Cancer
What should you be aware of when monitoring for toxicities linked with newer agents?
PhD, MSN, APRN-BC, AOCN
How do you select and sequence treatments in the upfront and relapsed/refractory settings?
What are some of the emerging therapies and their mechanisms of action?
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.
Bot trap - Don't go here
to learn more.